BioGend Therapeutics Co., Ltd. 6733.TWO Stock
BioGend Therapeutics Co., Ltd. Price Chart
BioGend Therapeutics Co., Ltd. 6733.TWO Financial and Trading Overview
| BioGend Therapeutics Co., Ltd. stock price | 37.45 TWD |
| Previous Close | 44.05 TWD |
| Open | 43.5 TWD |
| Bid | 43.65 TWD x N/A |
| Ask | 43.8 TWD x N/A |
| Day's Range | 43.4 - 44.5 TWD |
| 52 Week Range | 19.1 - 48.9 TWD |
| Volume | 821.49K TWD |
| Avg. Volume | 2.39M TWD |
| Market Cap | 5.37B TWD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.3 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
6733.TWO Valuation Measures
| Enterprise Value | 4.54B TWD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 6.4012322 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
BioGend Therapeutics Co., Ltd. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 93.62% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 48.9 TWD |
| 52 Week Low | 19.1 TWD |
| 50-Day Moving Average | 39.66 TWD |
| 200-Day Moving Average | 27.44 TWD |
6733.TWO Share Statistics
| Avg. Volume (3 month) | 2.39M TWD |
| Avg. Daily Volume (10-Days) | 2.33M TWD |
| Shares Outstanding | 123.08M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 48.44% |
| % Held by Institutions | 5.20% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | 0.31 TWD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 22.78M TWD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -1.76 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 6.819 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of BioGend Therapeutics Co., Ltd.
| Country | Taiwan |
| State | N/A |
| City | Taipei |
| Address | No.3-2, Park Street |
| ZIP | 115 |
| Phone | 886 2 2655 8366 |
| Website | https://www.biogend.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
BioGend Therapeutics Co., Ltd. develops regenerative bio-orthopaedic products. It is developing BiG-001 and BiG-006, an osteoinductive bone graft substitute; and BiG-009, an autologous cartilage repair system. The company was founded in 2016 and is based in Taipei, Taiwan.
Q&A For BioGend Therapeutics Co., Ltd. Stock
What is a current 6733.TWO stock price?
BioGend Therapeutics Co., Ltd. 6733.TWO stock price today per share is 37.45 TWD.
How to purchase BioGend Therapeutics Co., Ltd. stock?
You can buy 6733.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BioGend Therapeutics Co., Ltd.?
The stock symbol or ticker of BioGend Therapeutics Co., Ltd. is 6733.TWO.
Which industry does the BioGend Therapeutics Co., Ltd. company belong to?
The BioGend Therapeutics Co., Ltd. industry is Biotechnology.
How many shares does BioGend Therapeutics Co., Ltd. have in circulation?
The max supply of BioGend Therapeutics Co., Ltd. shares is 123.08M.
What is BioGend Therapeutics Co., Ltd. Price to Earnings Ratio (PE Ratio)?
BioGend Therapeutics Co., Ltd. PE Ratio is now.
What was BioGend Therapeutics Co., Ltd. earnings per share over the trailing 12 months (TTM)?
BioGend Therapeutics Co., Ltd. EPS is -1.3 TWD over the trailing 12 months.
Which sector does the BioGend Therapeutics Co., Ltd. company belong to?
The BioGend Therapeutics Co., Ltd. sector is Healthcare.